Clinical Trial Update: AMP as a Better Delivery System of Adenosine [Phase 1]

View source ↗

Summary

Phase 1 clinical trial evaluating AMP as a better delivery system for adenosine in ischemia was terminated; results posted in 2019.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Ischemia

Drugs mentioned

• AMP

Snippet

Sponsor: Vanderbilt University Medical Center | Conditions: Ischemia | Phase 1 | Status: TERMINATED | Results posted: 2019-05-07